According to the latest report published by Credence Research, Inc. “Direct-to-Consumer (DTC) Genetic Testing Market -
Growth, Future Prospects and Competitive Analysis,
2018-2026,” the global direct-to-consumer genetic testing market was
valued at US$ 117.1 Mn in 2017 and expected to reach US$ 611.2 Mn by
2026, expanding at a CAGR of 19.4% from 2018 to 2026.
Browse the full report Direct-to-Consumer (DTC) Genetic Testing Market - Growth, Future Prospects and Competitive Analysis, 2018-2026 report at http://www.credenceresearch.com/report/direct-to-consumer-genetic-testing-market
Market Insights
The global Direct-to-Consumer (DTC)
genetic testing market is projected to surge with a double digit CAGR of
19.4% during the forecast period from 2018 to 2026. Rising awareness
about genome testing and risk of genetic diseases and increased
inquisitiveness about the assessment of lineage and ancestry are the
major driving factors for the global market. Over the past 10 years, the
global DTC genetic testing market has experienced extensive variations
in term of market value due to the regulatory constraints. With rampant
commercialization of DTC genetic testing products in the U.S., the
market was going to be establish until FDA ordered the manufacturers to
withdraw the products owing to potential health consequences of test
generated results. However, with the revived approval of these products,
supported by validating data from the market players in 2015, the DTC
genetic testing market is estimated to experience lucrative growth
during the forecast period.
Based on the sales channel, the global
direct-to-consumer genetic testing market is segmented into on-line
sales, OTC sales, and doctor’s office. DTC genetic testing market sales
are predominantly driven by on-line sales, wherein the products are made
available for sale via the internet. Such products are available
through manufacturers’ online portals thus ensuring a vast outreach
across boundaries. According to the analysis, on-line sales segment
dominated the market in 2017 and expected to retain its dominance during
the forecast period.
Based on the business model, the global
direct-to-consumer genetic testing market is segmented into genome data
bank material, individual health planning, comprehensive genome tests,
medical precision tests and restricted trait tests. The currently
available DTC services include testing for ancestry data with
information related to family lineage, identification of health risks
and risk of acquiring hereditary diseases, information pertaining to
genomic pattern and knowledge of personal traits. In terms of market
value, genome data bank material model dominated the global DTC genetic
testing market in 2017 and expected to witness perpetual lead throughout
the forecast period.
Based on the geographical demarcation,
North America led the global DTC genetic testing market in 2017 with a
market share of over 45%. Increasing awareness about the risk of genetic
diseases and growing proactive tendency among the public about
prevention and efficient management of chronic diseases mainly drive the
North America market. Additionally, inquisitiveness about knowledge of
lineage also prominently determine the significant sales in this region.
Furthermore, Asia Pacific is estimated to be the fastest growing
regional market during the forecast period, growing at a CAGR of above
20%. The growth of this region is mainly attributed to rapid evolution
of healthcare infrastructure and increasing awareness about the
availability of such tests kits. Key market players in the global DTC
genetic testing market include deCODE genetics, Inc., Color Genomics,
Inc., Gene By Gene, Ltd., Ancestry.com, Inc., Myriad Genetics, Inc.,
Genleven Oy, 23andMe, Inc., and CENTOGENE AG.
Download
Free Sample Request: http://www.credenceresearch.com/sample-request/57820
About
Us:
Credence
Research is a worldwide market research and counseling firm that serves driving
organizations, governments, non-legislative associations, and not-for-benefits.
We offer our customers some assistance with making enduring enhancements to
their execution and understand their most imperative objectives. Over almost a
century, we've manufactured a firm extraordinarily prepared for this
task.
Media
Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
E-mail: sales@credenceresearch.com
Ph.: 1-800-361-8290
Website: http://www.credenceresearch.com

No comments:
Post a Comment